Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer

NCT02366819 · clinicaltrials.gov ↗

PHASE4

Phase

SUSPENDED

Status

36

Enrollment

OTHER

Sponsor class

Stopped Pending data analysis

Conditions

Esophageal Adenocarcinoma
Gastric Adenocarcinoma
Stage IIB Gastric Cancer
Stage IIIA Esophageal Adenocarcinoma
Stage IIIA Gastric Cancer
Stage IIIB Esophageal Adenocarcinoma
Stage IIIB Gastric Cancer
Stage IIIC Esophageal Adenocarcinoma
Stage IIIC Gastric Cancer

Interventions

DRUG: Oxaliplatin
DRUG: Leucovorin Calcium
DRUG: Irinotecan Hydrochloride
DRUG: Fluorouracil
PROCEDURE: Conventional Surgery

Sponsor

University of Chicago

Collaborators

[object Object]